As the European Commission aspires to introduce a Unitary SPC, Tony Rollins examines the evidence on how effective the existing regime for patent extension in Europe has been R&D is crucial to the ...
The European Commission’s effort to relax supplementary protection certificates to help generic-drug makers and biosimilars producers has sparked strong opposition from the research-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results